Daptomycin for the treatment of gram-positive infections after cardiac surgery

被引：0
|
作者：
Luchting, B. [1 ]
Weis, F. [1 ]
Heyn, J. [1 ]
Beiras-Fernandez, A. [2 ,3 ]
机构：
[1] Klinikum Univ Munchen, Klin Anaesthesiol, Munich, Germany
[2] Klinikum Univ Munchen, Herzchirurg Klin & Poliklin, Munich, Germany
[3] Klinikum Johann Wolfgang Goethe Univ, D-60590 Frankfurt, Germany
来源：
MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN | 2013年 / 108卷 / 01期
关键词：
Gram-positive Infections; Daptomycin; Cardiac surgery; Resistences; Efficacy; RESISTANT STAPHYLOCOCCUS-AUREUS; MAJOR HEART-SURGERY; POSTOPERATIVE MEDIASTINITIS; CLINICAL-EVIDENCE; JOINT INFECTIONS; VANCOMYCIN; THERAPY; ENDOCARDITIS; BACTEREMIA; PATIENT;
D O I：
10.1007/s00063-012-0163-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Background and method. Surgical infection remains a main cause of death after heart surgery, despite advances in pharmacological therapy. Daptomycin is a cyclic lipopeptide antibiotic, useful in gram-positive organisms resistant to standard treatment, including vancomycin. The aim of this study was to describe the use of daptomycin regarding efficacy, efficiency and safety in patients with gram-positive infections after heart surgery using a retrospective analysis on 49 adult patients. Conclusion. Daptomycin shows excellent in vitro and in vivo activity against gram-positive organisms, such as Enterococcus faecalis, Enterococcus faecium, Staphylococcus aureus, especially MRSA. Daptomycin is also effective against increasing vancomycin-resistant or vancomycin-intermediate S. aureus.
引用
收藏
页码：59 / 62
页数：4
相关论文
共 50 条
  • [11] Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections
    Steenbergen, JN
    Alder, J
    Thorne, GM
    Tally, FP
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (03) : 283 - 288
  • [12] Daptomycin: a rapidly bactericidal lipopeptide for the treatment of Gram-positive infections
    Konafani, Zeina A.
    Corey, G. Ralph
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2007, 5 (02) : 177 - 184
  • [13] Daptomycin, a new drug class for the treatment of gram-positive infections
    Alder, JD
    DRUGS OF TODAY, 2005, 41 (02) : 81 - 90
  • [14] Daptomycin therapy for Gram-positive bacterial infections: a retrospective study of 30 cardiac surgery patients
    E Douka
    G Stravopodis
    I Mpisiadis
    D Markantonaki
    S Geroulanos
    G Saroglou
    Critical Care, 12 (Suppl 2):
  • [15] Gram-Positive Blood Stream Infections in Children After Cardiac Surgery
    Gurlevik, Sibel Lacinel
    Baris, Meral
    Subasi, Berivan
    Tomrukcu, Fatih
    JOURNAL OF PEDIATRIC INFECTION, 2024, 18 (01): : e7 - e11
  • [16] Clinical Experience with Daptomycin for the Treatment of Gram-positive Infections in Children and Adolescents
    Syriopoulou, Vassiliki
    Dailiana, Zoe
    Dmitriy, Nisichenko
    Utili, Riccardo
    Pathan, Rashidkhan
    Hamed, Kamal
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (05) : 511 - 516
  • [17] Daptomycin: a new treatment for insidious infections due to gram-positive pathogens
    Cottagnoud, Philippe
    SWISS MEDICAL WEEKLY, 2008, 138 (7-8) : 93 - 99
  • [18] Daptomycin therapy for Gram-positive infections in cancer patients
    Hogan, H.
    Raad, I.
    Rolston, K.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S471 - S471
  • [19] Daptomycin: An important addition to the management of gram-positive infections
    Rolston, Kenneth V. I.
    Segreti, John
    AMERICAN JOURNAL OF MEDICINE, 2007, 120 (10): : S1 - S3
  • [20] Daptomycin for the Treatment of Gram-Positive Periprosthetic Hip Infections: Can Daptomycin Prevent the Implant Removal?
    Oe, Kenichi
    Sawada, Masahiro
    Nakamura, Tomohisa
    Iida, Hirokazu
    Saito, Takanori
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (06)
12345